Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Midostaurin, quizartinib, and gilteritinib have been approved in the last years for the treatment of Acute Myeloid Leukemia (AML), and more Tyrosine Kinase Inhibitors (TKIs) targeting FLT3 are being developed such as crenolanib.
…